Return to site
Return to site

Synceres Biosciences Completed A Round of Financing to Expand Synbio Product Pipelines

· Trends

Recently, Synceres Biosciences completed A round of financing of nearly 100 million yuan for the R&D and operation of the company's new product pipeline, pilot test and team expansion.

 

Synceres is an international bio-tech company engaged in the frontier of synthetic biology related R&D. The company is co-founded by business elites and brilliant scientists with strong academic backgrounds. Synceres uses high-throughput synthetic bio-engineering technologies to provide innovative manufacturing solutions. Through systematic engineering at the level of molecular (DNA manipulation, direct evolution of enzymes etc.), cellular and sub-cellular (metabolic network rewriting and compartmentalization) and culturing (fermentation optimization), Synceres manages to commercialize the designed microbial cell factories for large-scale bio-manufacturing of various products. The market share is continuously expanding in the fields of biopharmaceuticals, tobacco, cosmetics, spices, fuel, solvent, and agriculture. 

 

At present, the lab testing of three pipelines of Synceres has been completed and is now entering into the pilot stage.

 

Subscribe
Previous
PAM2LBiotechnologies Completed the Angel Round Financing...
Next
Edible Microbial Synthetic Protein Startup Changing...
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
Necessary Cookies
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
Analytics Cookies
These cookies help us better understand how visitors interact with our website and help us discover errors.
Preferences Cookies
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save